ProKidney Corp.
PROK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.8% | -3.9% | 202.6% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | -544.2% | 100% | 100% | 100% |
| R&D Expenses | $27 | $26 | $27 | $40 |
| G&A Expenses | $0 | $14 | $14 | $12 |
| SG&A Expenses | $11 | $14 | $14 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $37 | $40 | $42 | $52 |
| Operating Income | -$39 | -$40 | -$41 | -$52 |
| % Margin | -17,759.9% | -17,967.9% | -17,994.8% | -67,856.6% |
| Other Income/Exp. Net | $3 | $4 | $4 | $5 |
| Pre-Tax Income | -$35 | -$36 | -$37 | -$47 |
| Tax Expense | $1 | $1 | $1 | $2 |
| Net Income | -$16 | -$17 | -$17 | -$21 |
| % Margin | -7,589.4% | -7,489.6% | -7,275.7% | -27,997.4% |
| EPS | -0.12 | -0.13 | -0.13 | -0.17 |
| % Growth | 7.7% | 0% | 23.5% | – |
| EPS Diluted | -0.12 | -0.13 | -0.13 | -0.17 |
| Weighted Avg Shares Out | 135 | 131 | 129 | 128 |
| Weighted Avg Shares Out Dil | 135 | 131 | 129 | 128 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $4 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $2 | $2 |
| EBITDA | -$34 | -$35 | -$36 | -$45 |
| % Margin | -15,614.3% | -15,679.2% | -15,548.3% | -59,480.3% |